Nasser K. Altorki

39.5k total citations · 7 hit papers
378 papers, 22.4k citations indexed

About

Nasser K. Altorki is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Nasser K. Altorki has authored 378 papers receiving a total of 22.4k indexed citations (citations by other indexed papers that have themselves been cited), including 234 papers in Pulmonary and Respiratory Medicine, 137 papers in Surgery and 103 papers in Oncology. Recurrent topics in Nasser K. Altorki's work include Lung Cancer Diagnosis and Treatment (133 papers), Lung Cancer Treatments and Mutations (108 papers) and Esophageal Cancer Research and Treatment (87 papers). Nasser K. Altorki is often cited by papers focused on Lung Cancer Diagnosis and Treatment (133 papers), Lung Cancer Treatments and Mutations (108 papers) and Esophageal Cancer Research and Treatment (87 papers). Nasser K. Altorki collaborates with scholars based in United States, Canada and United Kingdom. Nasser K. Altorki's co-authors include Jeffrey L. Port, Brendon M. Stiles, Paul C. Lee, David B. Skinner, Vivek Mittal, Subroto Paul, Andrew J. Dannenberg, Daniel M. Libby, Kotha Subbaramaiah and Claudia I. Henschke and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Nasser K. Altorki

362 papers receiving 21.9k citations

Hit Papers

Early Lung Cancer Action Project: overall design and find... 1999 2026 2008 2017 1999 2015 2018 2010 2008 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Early Lung Cancer Action Project: overall design and findings from baseline screening
    1999 1.9k citations Nasser K. Altorki et al. profile →
  2. Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance
    2015 1.4k citations Hyejin Choi, Seongho Ryu et al. profile →
  3. The lung microenvironment: an important regulator of tumour growth and metastasis
    2018 795 citations Nasser K. Altorki, Dingcheng Gao et al. profile →
  4. Thoracoscopic lobectomy is associated with lower morbidity than open lobectomy: A propensity-matched analysis from the STS database
    2010 586 citations Subroto Paul, Nasser K. Altorki et al. Journal of Thoracic and Cardiovascular Surgery profile →
  5. The Number of Lymph Nodes Removed Predicts Survival in Esophageal Cancer: An International Study on the Impact of Extent of Surgical Resection
    2008 413 citations Nasser K. Altorki et al. profile →
  6. Neoadjuvant durvalumab with or without stereotactic body radiotherapy in patients with early-stage non-small-cell lung cancer: a single-centre, randomised phase 2 trial
    2021 210 citations Nasser K. Altorki, Timothy E. McGraw et al. profile →
  7. Overall survival with adjuvant atezolizumab after chemotherapy in resected stage II-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase III trial
    2023 126 citations Nasser K. Altorki et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nasser K. Altorki United States 77 11.0k 6.5k 5.7k 5.4k 2.9k 378 22.4k
Samuel Singer United States 90 16.7k 1.5× 8.1k 1.3× 4.9k 0.9× 7.3k 1.4× 1.4k 0.5× 331 28.9k
Quynh‐Thu Le United States 79 7.0k 0.6× 7.8k 1.2× 5.8k 1.0× 6.7k 1.2× 4.3k 1.5× 461 25.4k
Heikki Joensuu Finland 97 12.6k 1.1× 12.8k 2.0× 7.1k 1.2× 8.4k 1.6× 4.2k 1.5× 583 35.5k
Wilko Weichert Germany 73 5.8k 0.5× 10.1k 1.6× 2.9k 0.5× 8.6k 1.6× 2.4k 0.8× 516 22.1k
Peter Schirmacher Germany 86 6.7k 0.6× 11.6k 1.8× 6.8k 1.2× 10.9k 2.0× 2.0k 0.7× 681 36.7k
David G. Bostwick United States 90 16.2k 1.5× 3.7k 0.6× 5.7k 1.0× 6.6k 1.2× 1.8k 0.6× 458 27.2k
Everett E. Vokes United States 95 15.5k 1.4× 19.2k 3.0× 7.6k 1.3× 9.6k 1.8× 2.2k 0.8× 774 36.3k
Giampaolo Tortora Italy 69 7.8k 0.7× 13.8k 2.1× 2.5k 0.4× 9.9k 1.8× 1.9k 0.7× 639 24.4k
Kenneth J. O’Byrne Australia 72 10.5k 1.0× 12.7k 2.0× 1.5k 0.3× 8.4k 1.6× 1.8k 0.6× 598 23.7k
Richard S. Finn United States 76 11.6k 1.1× 16.3k 2.5× 3.6k 0.6× 9.0k 1.7× 2.7k 0.9× 370 38.2k

Countries citing papers authored by Nasser K. Altorki

Since Specialization
Citations

This map shows the geographic impact of Nasser K. Altorki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nasser K. Altorki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nasser K. Altorki more than expected).

Fields of papers citing papers by Nasser K. Altorki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nasser K. Altorki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nasser K. Altorki. The network helps show where Nasser K. Altorki may publish in the future.

Co-authorship network of co-authors of Nasser K. Altorki

This figure shows the co-authorship network connecting the top 25 collaborators of Nasser K. Altorki. A scholar is included among the top collaborators of Nasser K. Altorki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nasser K. Altorki. Nasser K. Altorki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Altorki, Nasser K., Bhavneet Bhinder, Alain Borczuk, et al.. (2024). A signature of enhanced proliferation associated with response and survival to anti-PD-L1 therapy in early-stage non-small cell lung cancer. Cell Reports Medicine. 5(3). 101438–101438. 2 indexed citations
3.
Nasar, Abu, Jonathan Villena‐Vargas, Oliver S. Chow, et al.. (2023). Should sampling of three N2 stations be a quality metric for curative resection of stage I lung cancer?. Journal of Thoracic and Cardiovascular Surgery. 168(5). 1337–1345.e5. 4 indexed citations
4.
Altorki, Nasser K., et al.. (2023). Regulation of PD-L1 Trafficking from Synthesis to Degradation. Cancer Immunology Research. 11(7). 866–874. 11 indexed citations
5.
Gray, Jhanelle E., Nefeli Georgoulia, Alice Wang, et al.. (2023). The RESECT study: Factors associated with overall survival (OS) and relapse-free survival (RFS) among patients with stages I–III resected NSCLC without known EGFR mutations.. Journal of Clinical Oncology. 41(16_suppl). 8541–8541. 1 indexed citations
6.
Kamel, Mohamed, Jonathan Villena‐Vargas, Mohamed Rahouma, et al.. (2019). National trends and perioperative outcomes of robotic resection of thymic tumours in the United States: a propensity matching comparison with open and video-assisted thoracoscopic approaches†. European Journal of Cardio-Thoracic Surgery. 56(4). 762–769. 21 indexed citations
7.
Kamel, Mohamed, Mohamed Rahouma, Brendon M. Stiles, et al.. (2017). Robotic Thymectomy: Learning Curve and Associated Perioperative Outcomes. Journal of Laparoendoscopic & Advanced Surgical Techniques. 27(7). 685–690. 23 indexed citations
8.
9.
Kamel, Mohamed, Abu Nasar, Brendon M. Stiles, Nasser K. Altorki, & Jeffrey L. Port. (2016). Video-Assisted Thoracoscopic Lobectomy Is the Preferred Approach Following Induction Chemotherapy. Journal of Laparoendoscopic & Advanced Surgical Techniques. 27(5). 495–500. 28 indexed citations
10.
Remark, Romain, Christian Becker, Jorge Gómez, et al.. (2014). The Non–Small Cell Lung Cancer Immune Contexture. A Major Determinant of Tumor Characteristics and Patient Outcome. American Journal of Respiratory and Critical Care Medicine. 191(4). 377–390. 205 indexed citations
11.
Lee, Paul C., Abu Nasar, Jeffrey L. Port, et al.. (2013). Long-Term Survival After Lobectomy for Non-Small Cell Lung Cancer by Video-Assisted Thoracic Surgery Versus Thoracotomy. The Annals of Thoracic Surgery. 96(3). 951–961. 104 indexed citations
12.
Chaudhri, Virendra K., Raffaella Sordella, Edward D. Karoly, et al.. (2013). Metabolic Alterations in Lung Cancer–Associated Fibroblasts Correlated with Increased Glycolytic Metabolism of the Tumor. Molecular Cancer Research. 11(6). 579–592. 77 indexed citations
13.
Gao, Dingcheng, Natasha Joshi, Hyejin Choi, et al.. (2012). Myeloid Progenitor Cells in the Premetastatic Lung Promote Metastases by Inducing Mesenchymal to Epithelial Transition. Cancer Research. 72(6). 1384–1394. 234 indexed citations
14.
Mathé, Ewy A., Giang Huong Nguyen, Elise D. Bowman, et al.. (2009). MicroRNA Expression in Squamous Cell Carcinoma and Adenocarcinoma of the Esophagus: Associations with Survival. Clinical Cancer Research. 15(19). 6192–6200. 319 indexed citations
15.
Gnjatic, Sacha, Nasser K. Altorki, Derek Ng Tang, et al.. (2009). NY-ESO-1 DNA Vaccine Induces T-Cell Responses That Are Suppressed by Regulatory T Cells. Clinical Cancer Research. 15(6). 2130–2139. 58 indexed citations
16.
Hughes, Duncan, Peiying Yang, Robert A. Newman, et al.. (2008). NAD+-Dependent 15-Hydroxyprostaglandin Dehydrogenase Regulates Levels of Bioactive Lipids in Non–Small Cell Lung Cancer. Cancer Prevention Research. 1(4). 241–249. 39 indexed citations
17.
Güre, Ali O., Ramon Chua, Barbara Williamson, et al.. (2005). Cancer-Testis Genes Are Coordinately Expressed and Are Markers of Poor Outcome in Non–Small Cell Lung Cancer. Clinical Cancer Research. 11(22). 8055–8062. 294 indexed citations
18.
Klemperer, John D., Wilson Ko, Karl H. Krieger, et al.. (1998). Cardiac Operations in Patients With Cirrhosis. The Annals of Thoracic Surgery. 65(1). 85–87. 109 indexed citations
19.
Loinaz, Carmelo & Nasser K. Altorki. (1997). PITFALLS AND COMPLICATIONS OF COLON INTERPOSITION. Chest Surgery Clinics of North America. 7(3). 533–550. 8 indexed citations
20.
Helm, Robert E., John D. Klemperer, Todd K. Rosengart, et al.. (1996). Intraoperative autologous blood donation preserves red cell mass but does not decrease postoperative bleeding. The Annals of Thoracic Surgery. 62(5). 1431–1441. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Samuel Singer Breakdown of academic impact, for papers by Quynh‐Thu Le Breakdown of academic impact, for papers by Heikki Joensuu Breakdown of academic impact, for papers by Wilko Weichert Breakdown of academic impact, for papers by Peter Schirmacher Breakdown of academic impact, for papers by David G. Bostwick Breakdown of academic impact, for papers by Everett E. Vokes Breakdown of academic impact, for papers by Giampaolo Tortora Breakdown of academic impact, for papers by Kenneth J. O’Byrne Breakdown of academic impact, for papers by Richard S. Finn
Rankless by CCL
2026